TLDR Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.
The mini-review "Sex differences in COVID-19: the role of androgens in disease severity and progression" suggests that androgens, like testosterone, may facilitate the entry of the SARS-CoV2 virus into host cells by promoting the transcription of Transmembrane protease serine 2 (TMPRSS2), a protein used by the virus for entry. Variants in the androgen receptor gene, associated with conditions like androgenetic alopecia and prostate cancer, have been linked to worse COVID-19 outcomes. The paper concludes that androgen sensitivity could be a key factor in determining COVID-19 disease severity, and sensitivity tests might help predict patient outcomes. Ongoing clinical trials are exploring androgen suppression therapies as a potential COVID-19 treatment, but these preliminary results should be interpreted with caution.View this study on link.springer.com →
Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.
Male pattern hair loss could hint at androgens affecting COVID-19 severity.
Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.
Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.
Genetic variation in the androgen receptor gene mainly causes early-onset hair loss, with maternal inheritance playing a key role.
Shorter CAG repeats may cause hair and skin issues, while longer ones may link to acne.